These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34070107)

  • 1. MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia.
    Gębarowska K; Mroczek A; Kowalczyk JR; Lejman M
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL).
    Mavrakis KJ; Van Der Meulen J; Wolfe AL; Liu X; Mets E; Taghon T; Khan AA; Setty M; Rondou P; Vandenberghe P; Delabesse E; Benoit Y; Socci NB; Leslie CS; Van Vlierberghe P; Speleman F; Wendel HG
    Nat Genet; 2011 Jun; 43(7):673-8. PubMed ID: 21642990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
    Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML
    Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers.
    Drobna M; Szarzyńska-Zawadzka B; Dawidowska M
    Blood Rev; 2018 Nov; 32(6):457-472. PubMed ID: 29703513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
    Xi Y; Li J; Zhang P; Bai W; Gao N; Bai W; Zhang Y; Wu Y; Ning Y
    Exp Mol Pathol; 2015 Oct; 99(2):297-302. PubMed ID: 26231295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia.
    Mets E; Van Peer G; Van der Meulen J; Boice M; Taghon T; Goossens S; Mestdagh P; Benoit Y; De Moerloose B; Van Roy N; Poppe B; Vandesompele J; Wendel HG; Van Vlierberghe P; Speleman F; Rondou P
    Haematologica; 2014 Aug; 99(8):1326-33. PubMed ID: 24895337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies.
    Sabarimurugan S; Madurantakam Royam M; Kumarasamy C; Kodiveri Muthukaliannan G; Samiappan S; Jayaraj R
    Medicine (Baltimore); 2019 Mar; 98(9):e14569. PubMed ID: 30817574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases.
    Doerrenberg M; Kloetgen A; Hezaveh K; Wössmann W; Bleckmann K; Stanulla M; Schrappe M; McHardy AC; Borkhardt A; Hoell JI
    Genes Chromosomes Cancer; 2017 Feb; 56(2):159-167. PubMed ID: 27717083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-211 attenuates cell proliferation in T-cell lymphoblastic lymphoma through targeting TCF12.
    An L; Li X; Yang J
    Leuk Res; 2021 Nov; 110():106653. PubMed ID: 34298254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias.
    Malik D; Kaul D; Chauhan N; Marwaha RK
    Mol Cancer; 2014 Jul; 13():175. PubMed ID: 25037230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia.
    Ma M; Wang X; Tang J; Xue H; Chen J; Pan C; Jiang H; Shen S
    Front Med; 2012 Dec; 6(4):416-20. PubMed ID: 23065427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancements in the Regulatory Role of microRNAs in Childhood Acute Lymphoblastic Leukemia: Mechanisms and Clinical Implications.
    Deng W
    Technol Cancer Res Treat; 2024; 23():15330338241273143. PubMed ID: 39099455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.
    El-Khazragy N; Noshi MA; Abdel-Malak C; Zahran RF; Swellam M
    J Cell Biochem; 2019 Apr; 120(4):6315-6321. PubMed ID: 30362157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
    Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001.
    Burns MA; Place AE; Stevenson KE; Gutiérrez A; Forrest S; Pikman Y; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Asselin BL; Athale UH; Clavell LA; Cole PD; Gennarini LM; Kahn JM; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Sulis ML; Welch JJG; Neuberg DS; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28719. PubMed ID: 33026184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
    Ghodousi ES; Rahgozar S
    J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
    Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
    Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.